Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
131.4 USD | +0.48% | +4.52% | +20.59% |
04:13pm | Goldman Sachs Raises Price Target on Merck & Company to $144 From $139 | MT |
03:14pm | Leerink Partners Raises Price Target on Merck & Company to $136 From $132 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.59% | 331B | |
+26.12% | 653B | |
+26.27% | 556B | |
-6.40% | 354B | |
+5.03% | 296B | |
+12.60% | 233B | |
+5.53% | 201B | |
-9.65% | 193B | |
-5.79% | 144B | |
-11.69% | 143B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck & Co.'s Keytruda Improves Disease-Free Survival as Adjuvant Therapy for Lung Cancer